$SPCX

SpaceX Faced First Lockup Expiry After AI Spending Overshadowed Strong Earnings

SpaceX (SPCX) saw its first IPO lockup expire on Thursday, making over 911 million shares eligible for sale after a selloff tied to its first earnings as a public company. In Q2, revenue rose to $7.81B from $4.07B, and net loss narrowed to $541M ($0.09/share). Investors also focused on $18.4B quarterly capex, including $15.8B for AI infrastructure.

Original reporting
Published Aug 6, 2026, 11:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 12:42 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SpaceX Faced First Lockup Expiry After AI Spending Overshadowed Strong Earnings — source image
Decision brief

The 30-second read

$SPCXBearishMed
01

Why it matters

The key trade driver is the combination of a large eligible-share unlock (911M+ shares) and investor focus on very high quarterly capex for AI infrastructure, raising near-term cash-flow concerns.

02

Market read

Traders may reassess near-term risk due to increased float from the lockup expiry, even with reported revenue and EPS beats.

03

What to watch

Actual selling pace may be gradual, and the market may already price lockup mechanics; cash-flow details beyond capex are not provided here.

Relevance 7/10Novelty 6/10Timing: lockup expiry on Thursday, immediately increasing tradable float

Background

The article frames SpaceX as a newly public company whose inaugural earnings triggered a sharp selloff, followed by the first major lockup expiry.

Company-level read

Ticker impact

$SPCXBearishMedium confidence
Context

SpaceX’s first IPO lockup expired, letting early investors sell 911M+ shares, after Q2 earnings and heavy AI capex drove selloff concerns.

Expected impact

Near-term downside or higher volatility risk as eligible shares hit the market; longer-term view depends on AI capex cash-flow trajectory.

Evidence & confidence

The article ties the lockup expiry to negative sentiment and highlights $18.4B quarterly capex, including $15.8B for AI infrastructure, which can worsen near-term cash-flow expectations.

Market effects

Could reinforce investor skepticism around AI-driven capex intensity in space/launch and adjacent infrastructure plays.

Primarily affects US-listed sentiment for high-growth space/AI infrastructure names.

Limited direct global spillover, but may influence broader AI capex and supply-overhang narratives.

Counterpoint

Earnings beat and narrowing net loss could offset supply overhang if buyers absorb selling and capex concerns prove manageable.

Key entities

  • Space Exploration Technologies Corp.

    Subject of the article; IPO lockup expiry and Q2 results with heavy AI capex are cited as drivers of sentiment.

Related articles

$SPCXMed

SpaceX Stock Drops 10% as Revenue Beats Expectations

SpaceX shares fell about 10% after its first earnings report as a public company, despite a revenue and adjusted-loss beat, according to Reuters and CNBC. SpaceX reported Q2 revenue of $7.81B (vs est. ~$6.93B) and a net loss of $541M. Investors focused on $18.4B quarterly capex, including $15.83B for AI infrastructure, plus potential post-IPO lock-up selling.

$SPCXMed

SPCX Surges 16%: Lockup Expiration Passes Cleanly

SpaceX (NASDAQ: SPCX) rose 15.8% on Aug. 7, closing at $133.11 after its first post-IPO lockup expiration on Aug. 6 passed without a broad insider selloff. The move followed Q2 results on Aug. 4, when revenue rose 92% to $7.81B. Next unlocks are Aug. 20 and late September.

$SPCXMed

Top Analyst Drops Sharp Take on SpaceX Stock

Argus Research upgraded newly public SpaceX (NASDAQ:SPCX) to Buy from Hold and set a $160 price target. The firm cited Q2 results with revenue up 92% to $7.8B versus $6.93B consensus and a $541M loss, better than expected. Argus expects revenue near $110B in 2027, supporting a ~20x projected-sales valuation amid concerns over rising AI infrastructure spending and share unlocks.

$SPCXMed

SpaceX Stock Surges 10.5% as Argus Sees Rapid AI Payback

Space Exploration Technologies (NASDAQ:SPCX) rose over 12% in Friday trading after Argus upgraded the stock to Buy from Hold and set a $160 price target. Argus cited faster-than-expected AI spending payback. The company reported Q revenue up 92% to $7.81B, adjusted EBITDA up to $3.54B, and AI revenue up 247% to $2.56B, with AI segment profit. Net loss was $541M and AI capex was $15.83B.